Alkermes Plc
(NASDAQ) ALKS
Alkermes Plc Financials at a Glance
Market Cap
$5.61B
Revenue (TTM)
$1.48B
Net Income (TTM)
$241.66M
EPS (TTM)
$1.43
P/E Ratio
23.54
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$34.12
Volume
59,288
Open
$33.89
Price
$34.12
Volume
59,288
Open
$33.89
Previous Close
$34.12
Daily Range
$33.85 - $34.45
52-Week Range
$25.16 - $36.48
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$34.12
Volume
59,288
Open
$33.89
Previous Close
$34.12
Daily Range
$33.85 - $34.45
52-Week Range
$25.16 - $36.48
ALKS News
Best Biotech ETFs to Buy in 2026
ALKS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alkermes Plc
Industry
Biotechnology
Sector
Health CareEmployees
2,050
CEO
Richard F. Pops
Website
www.alkermes.comHeadquarters
Dublin, 4, IE
ALKS Financials
Key Financial Metrics (TTM)
Gross Margin
86%
Operating Margin
17%
Net Income Margin
16%
Return on Equity
15%
Return on Capital
13%
Return on Assets
10%
Earnings Yield
4.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.61B
Shares Outstanding
166.25M
Volume
59.29K
Avg. Volume
2.25M
Financials (TTM)
Gross Profit
$1.27B
Operating Income
$253.96M
EBITDA
$330.89M
Operating Cash Flow
$520.75M
Capital Expenditure
$40.42M
Free Cash Flow
$480.33M
Cash & ST Invst.
$1.32B
Total Debt
$70.00M
Alkermes Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$384.55M
-10.6%
Gross Profit
$332.74M
-9.6%
Gross Margin
86.53%
N/A
Market Cap
$5.61B
N/A
Market Cap/Employee
$3.12M
N/A
Employees
1,800
N/A
Net Income
$49.34M
-66.3%
EBITDA
$76.50M
-57.8%
Quarterly Fundamentals
Net Cash
$1.25B
+84.8%
Accounts Receivable
$334.02M
-14.2%
Inventory
$196.63M
+7.5%
Long Term Debt
$63.25M
-8.8%
Short Term Debt
$6.75M
+9.4%
Return on Assets
9.55%
N/A
Return on Invested Capital
12.78%
N/A
Free Cash Flow
$170.09M
-5.8%
Operating Cash Flow
$170.07M
-10.7%